Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Exercise-Based Sensorimotor Physiotherapy for Postpartum Pelvic Health and Functional Recovery

9 juillet 2026 mis à jour par: Özge BAYKAN ÇOPUROĞLU

Effects of a 12-Week Exercise-Based Sensorimotor Physiotherapy Program on Postpartum Pelvic Health and Functional Recovery: A Stratified Randomized Controlled Trial

This study evaluated whether a 12-week exercise-based sensorimotor physiotherapy program could improve pelvic health and functional recovery in postpartum women. Participants were women aged 18-40 years who were between 6 weeks and 6 months after a singleton delivery. They were randomly assigned to either a sensorimotor physiotherapy group or a control group. The physiotherapy group received supervised exercises targeting pelvic floor activation, lumbopelvic motor control, sensory re-education, proprioceptive training, functional stabilization, and biofeedback-assisted training. The control group received standard postpartum education and home advice.

The main outcomes were pelvic motor control and perineal sensory function. Other outcomes included pelvic floor muscle strength, urinary symptoms, pelvic distress, core endurance, postural stability, pain intensity, and health-related quality of life. Outcomes were assessed at baseline, week 6, week 12, and week 24. The study aimed to determine whether structured sensorimotor physiotherapy provides greater benefits than standard postpartum advice and whether recovery patterns differ according to vaginal or cesarean delivery.

Aperçu de l'étude

Description détaillée

This was a prospective, single-center, assessor-blinded, stratified, parallel-group randomized controlled trial conducted in postpartum women. The study was designed to evaluate the effects of a structured 12-week exercise-based sensorimotor physiotherapy program on postpartum pelvic health, lumbopelvic motor control, sensory function, and functional recovery.

Eligible postpartum women were stratified according to delivery mode, vaginal delivery or cesarean delivery, and then randomly allocated to either the Sensorimotor Physiotherapy Group or the Control Group. The intervention group received supervised individual physiotherapy sessions twice weekly for 12 weeks, together with a structured home exercise program. The intervention included pelvic floor activation, lumbopelvic motor control training, proprioceptive exercises, sensory re-education, functional stabilization, and surface electromyography-assisted biofeedback. The control group received standard postpartum education and general home advice.

Outcome assessments were performed at baseline, week 6, week 12, and week 24 by blinded assessors. The primary focus was to determine whether the sensorimotor physiotherapy program improved pelvic motor control and perineal sensory function compared with standard postpartum advice. Secondary outcomes were used to evaluate broader functional and patient-reported recovery, including pelvic floor strength, urinary symptoms, pelvic distress, core endurance, postural stability, pain intensity, and health-related quality of life. Delivery mode was examined as an exploratory factor that could influence recovery patterns.

Type d'étude

Interventionnel

Inscription (Réel)

160

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Kayseri
      • Kayseri, Kayseri, Turquie (Türkiye), 38130
        • Kayseri University

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Women aged 18-40 years.
  • Postpartum women between 6 weeks and 6 months after delivery.
  • Singleton delivery.
  • Vaginal delivery or cesarean delivery.
  • Ability to understand and perform the required assessment procedures.
  • Ability to participate in the exercise-based intervention procedures.
  • Provision of written informed consent before enrollment.

Exclusion Criteria:

  • Third- or fourth-degree perineal tears.
  • Pelvic organ prolapse stage II or higher according to the POP-Q classification.
  • Active urinary tract infection or genital infection.
  • Previous pelvic or abdominal surgery unrelated to cesarean delivery.
  • Neurological conditions affecting lumbopelvic motor control.
  • Musculoskeletal conditions affecting lumbopelvic motor control.
  • Chronic pelvic pain syndromes.
  • Psychiatric disorders limiting participation.
  • Participation in structured physiotherapy or pelvic rehabilitation within the preceding 6 months.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Exercise-Based Sensorimotor Physiotherapy Program
A 12-week physiotherapist-led exercise-based sensorimotor physiotherapy program delivered individually twice weekly for approximately 45 minutes per session. The program included pelvic floor activation, diaphragmatic breathing, lumbopelvic motor control training, abdominal-pelvic floor synergy exercises, proprioceptive stimulation, tactile discrimination tasks, sensory re-education, functional stabilization, task-specific training, and surface electromyography-assisted biofeedback. Participants also completed a structured home exercise program for 15-20 minutes per day, five days per week.
A 12-week physiotherapist-led exercise-based sensorimotor physiotherapy program delivered individually twice weekly for approximately 45 minutes per session. The program included pelvic floor activation, diaphragmatic breathing, lumbopelvic motor control training, abdominal-pelvic floor synergy exercises, proprioceptive training, tactile discrimination tasks, sensory re-education, functional stabilization, task-specific training, and surface electromyography-assisted biofeedback. Participants also completed a structured home exercise program for 15-20 minutes per day, five days per week.
Autres noms:
  • Sensorimotor Physiotherapy
Autre: Standard Postpartum Education and Home Advice
A standard postpartum education and home advice program including information on postpartum anatomy, posture correction, bladder care, and general pelvic floor exercises. Participants received a printed home exercise leaflet and two telephone contacts at weeks 4 and 8 to encourage continuation of general advice. No supervised physiotherapy, individualized exercise progression, biofeedback, or structured sensorimotor training was provided.
A standard postpartum education and home advice program including information on postpartum anatomy, posture correction, bladder care, and general pelvic floor exercises. Participants received a printed home exercise leaflet and two telephone contacts at weeks 4 and 8 to encourage continuation of general advice. No supervised physiotherapy, individualized exercise progression, biofeedback, or structured sensorimotor training was provided.
Autres noms:
  • Standard Postpartum Advice

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Pelvic Motor Control Composite Score
Délai: Baseline, week 6, week 12, and week 24
Pelvic motor control was assessed using the Pelvic Motor Control Composite Score, an experimental composite index derived from surface electromyography-based parameters including normalized root mean square amplitude, onset latency, relaxation time, and contraction intermittency. Higher scores indicate better lumbopelvic motor control.
Baseline, week 6, week 12, and week 24
Change in Perineal Sensory Function
Délai: Baseline, week 6, week 12, and week 24
Perineal sensory function was assessed using pressure detection threshold measured with a calibrated handheld algometer and two-point discrimination measured with a precision caliper. Lower values indicate better sensory responsiveness and tactile discrimination.
Baseline, week 6, week 12, and week 24

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in Pelvic Floor Muscle Strength
Délai: Baseline, week 6, week 12, and week 24
Pelvic floor muscle strength was assessed using the Modified Oxford Scale and the PERFECT scheme. Higher scores indicate greater pelvic floor muscle strength and function.
Baseline, week 6, week 12, and week 24
Change in Urinary Incontinence Severity
Délai: Baseline, week 6, week 12, and week 24
Urinary incontinence severity was assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form. Higher scores indicate greater urinary incontinence severity.
Baseline, week 6, week 12, and week 24
Change in Pelvic Floor Distress
Délai: Baseline, week 6, week 12, and week 24
Pelvic floor-related distress was assessed using the Pelvic Floor Distress Inventory-20. Higher scores indicate greater pelvic floor symptom-related distress.
Baseline, week 6, week 12, and week 24
Change in Pelvic Floor Impact on Daily Function
Délai: Baseline, week 6, week 12, and week 24
The functional impact of pelvic floor symptoms was assessed using the Pelvic Floor Impact Questionnaire-7. Higher scores indicate greater negative impact of pelvic floor symptoms on daily activities and quality of life.
Baseline, week 6, week 12, and week 24
Change in Core Endurance
Délai: Baseline, week 6, week 12, and week 24
Core endurance was assessed using prone plank and side plank duration. Longer duration indicates better core endurance.
Baseline, week 6, week 12, and week 24
Change in Postural Stability
Délai: Baseline, week 6, week 12, and week 24
Postural stability was assessed using center-of-pressure displacement during stabilometry. Lower center-of-pressure displacement or sway area indicates better postural stability.
Baseline, week 6, week 12, and week 24
Change in Pain Intensity
Délai: Baseline, week 6, week 12, and week 24
Pain intensity was assessed using a 0-10 visual analogue scale. Higher scores indicate greater pain intensity.
Baseline, week 6, week 12, and week 24
Change in Health-Related Quality of Life
Délai: Baseline, week 6, week 12, and week 24
Health-related quality of life was assessed using the 12-item Short Form Health Survey version 2. Higher scores indicate better perceived health-related quality of life.
Baseline, week 6, week 12, and week 24

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chaise d'étude: Özge Çopuroğlu, Kayseri University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 mars 2024

Achèvement primaire (Réel)

1 décembre 2025

Achèvement de l'étude (Réel)

1 mars 2026

Dates d'inscription aux études

Première soumission

9 juillet 2026

Première soumission répondant aux critères de contrôle qualité

9 juillet 2026

Première publication (Réel)

14 juillet 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

14 juillet 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

9 juillet 2026

Dernière vérification

1 juillet 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner